Table 1.
Demographic data of renal transplant recipients with RCC
| Patient number | Gender | ESRD | Age at diagnosis of RCC (years) | Interval between transplant and RCC diagnosis (months) | ACKD | Immunosuppressive regimen |
|---|---|---|---|---|---|---|
| 1 | M | Chronic GN | 46 | 66 | − | Pred + Tac + MMF |
| 2 | F | Unknown | 70 | 15 | + | Pred + Tac + Aza |
| 3 | M | Chronic GN | 47 | 46 | − | Pred + CsA |
| 4 | M | Unknown | 48 | 147 | − | Pred + CsA |
| 5 | M | Unknown | 40 | 72 | − | Pred + Tac + MMF |
| 6 | M | Chronic GN | 55 | 128 | − | Pred + CsA |
| 7 | M | Chronic GN | 48 | 189 | − | Pred + CsA |
| 8 | M | Chronic GN | 52 | 56 | + | Pred + Tac + MMF |
| 9 | M | Unknown | 41 | 104 | + | Pred + CsA |
| 10 | F | Unknown | 43 | 40 | + | Pred + CsA + MMF |
| 11 | M | Unknown | 42 | 75 | + | Pred + CsA |
| 12 | M | Unknown | 49 | 258 | + | Pred + CsA |
ESRD end stage renal disease, RCC renal cell carcinoma, GN glomerulonephritis, ACKD acquired cystic kidney disease, Pred prednisolone, Tac tacrolimus, MMF mycophenolate mofetil, CsA cyclosporine